Carrier frequency of CFTR variants in the non-Caucasian populations by genome aggregation database (gnomAD)-based analysis
- PMID: 32484936
- DOI: 10.1111/ahg.12396
Carrier frequency of CFTR variants in the non-Caucasian populations by genome aggregation database (gnomAD)-based analysis
Abstract
The complexity in the molecular diagnosis of Cystic Fibrosis (CF) also depends on the variable prevalence/incidence of the disease associated with the wide CFTR allelic heterogeneity among different populations. In fact, CF incidence in Asian and African countries is underestimated and the few patients reported so far have rare or unique CFTR pathogenic variants. To obtain insights into CF variants profile and frequency, we used the large population sequencing data in the Genome Aggregation Database (gnomAD). We selected 207 CF-causing/varying clinical consequence variants from CFTR2 database and additional 15 variants submitted to the ClinVar database. Only 14 of these variants were found in the East-Asian population, while for South-Asian and African populations we identified 43 and 52 variants, respectively, confirming the peculiarity of the CFTR allelic spectrum with only few population-specific variants. These data could be used to optimize CFTR carrier screening in non-Caucasian subjects, choosing between the full gene sequencing and cost and time-effective targeted panels.
Keywords: CFTR; cystic fibrosis; gnomAD; non-Caucasian populations.
© 2020 John Wiley & Sons Ltd/University College London.
References
REFERENCES
-
- American College of Obstetricians and Gynecologists Committee on Genetics. (2011). ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis. Obstetrics and gynecology, 117, 1028-1031. https://doi.org/10.1097/AOG.0b013e31821922c2
-
- Bobadilla, J. L., Macek, M., Fine, J. P., & Farrell, P. M. (2002). Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening. Human Mutation, 19, 575-606. https://doi.org/10.1002/humu.10041
-
- Committee on Genetics (2017). Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstetrics and Gynecology, 129(3), e41-e55. https://doi.org/10.1097/AOG.0000000000001952
-
- D'Apice, M. R., Gambardella, S., Bengala, M., Russo, S., Nardone, A. M., Lucidi, V., … Novelli, G. (2004). Molecular analysis using DHPLC of cystic fibrosis: Increase of the mutation detection rate among the affected population in Central Italy. BMC Medical Genetics, 5, 8. https://doi.org/10.1186/1471-2350-5-8
-
- Farrell, P. M., White, T. B., Ren, C. L., Hempstead, S. E., Accurso, F., Derichs, N., … Sosnay, P. R. (2017). Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. The Journal of Pediatrics, 181S, S4-S15.e1. https://doi.org/10.1016/j.jpeds.2016.09.064
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical